Introduction {#s1}
============

'Quality of life' (QoL) was defined by the World Health Organization (WHO) as an \' ... individuals' perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns ... \' ([@DER171C21]). The WHOQOL measures QoL broadly according to 29 facets (e.g. self-esteem, mobility and safety). QoL measurement is important to identify aspects of fertility problems associated with poor QoL and advance research in health service-evaluation, patient satisfaction and policy-making through the use of a standard measurement tool ([@DER171C14]).

Psychosocial studies convincingly demonstrate a high incidence of negative reactions to infertility and its treatment ([@DER171C18]) that impact on overall life satisfaction and well-being ([@DER171C8]), success of treatment ([@DER171C3]), willingness to continue with treatment ([@DER171C16]), treatment evaluation ([@DER171C6]) and the long-term satisfaction people can hope to achieve if treatment is unsuccessful and they remain childless ([@DER171C7]). Therefore, the need to measure and take into account QoL in infertility is imperative and tackling this measurement hurdle could lead to improved patient outcomes.

The 14 existing self-report measures of infertility-specific distress, treatment reactions and QoL shown in [Supplementary data, Table S1](http://humrep.oxfordjournals.org/cgi/content/full/der171/DC1) do not fulfill the need for a fertility specific QoL assessment tool (the table includes details of development sample, content and reference). The fertility problem inventory (FPI: [@DER171C11]) is the most frequently used distress measure. However, the items were developed without consultation with people experiencing fertility problems and the validation sample comprised primarily Caucasian patients from a homogeneous socioeconomic category using assisted reproductive techniques. Further, the FPI assesses level of strain rather than the broader construct of QoL and does not separate effects due to infertility treatment from those due to childlessness, which is important given the emotional challenges of each. These issues apply to most measures listed in [Supplementary data, Table S1](http://humrep.oxfordjournals.org/cgi/content/full/der171/DC1). The most frequently used QoL measure was developed for women suffering from polycystic ovarian syndrome ([@DER171C5]). Several studies have examined its psychometric properties ([@DER171C9]) and used it to investigate moderators of QoL (e.g. obesity) and cross-cultural effects. Results confirm its reliability and the importance of cultural background as a moderator of QoL ([@DER171C15]; [@DER171C2]). However, this and other quality of life measures for infertility were designed for specific sub-populations (e.g. endometriosis, male factor) and therefore cannot be used as generic measure for all people with fertility problems.

In summary, the need for a quality of life measure for infertility measure has not been fully met. Given the importance of addressing this need, the European Society of Human Reproduction and Embryology (ESHRE) and the American Society of Reproductive Medicine (ASRM) joined forces with Merck-Serono S.A. Geneva-Switzerland (an affiliate of Merck KGaA Darmstadt, Germany) to create the fertility quality of life (FertiQoL) measure (2002--2009). The overall aim of the FertiQoL project was to develop an international instrument to measure QoL in men and women experiencing fertility problems. Secondary aims were to evaluate the psychometric properties of the tool and to translate FertiQoL in multiple languages. The development phase was carried out according to the protocol used for the development of the WHOQOL measure ([@DER171C20]) and is briefly described in the present article. However, the main focus of this report is on the psychometric evaluation.

Methods {#s2}
=======

Participants {#s2a}
------------

Men and women experiencing fertility difficulties with and without medical experience were sampled from one fertility clinic in Australia, Canada, New Zealand, UK and two clinics from the USA. Patient advocacy websites in these countries (i.e. ACCESS, American Fertility Association, Resolve, Infertility Awareness Association of Canada, International Consumer Support for Infertility, Infertility Network UK) hosted the online survey. The clinic sample consisted of 291 women and 75 men, and the online sample consisted of 1014 women and 34 men. The Ethics Committee of the School of Psychology, Cardiff University approved the online study and the Internal Review Board of each clinic approved the clinic studies.

Materials {#s2b}
---------

The *Background Information Form* covered socio-demographic status (e.g. age, education), medical history (e.g. current illness) and fertility-related characteristics (e.g. duration of infertility).

*FertiQoL prototype*: The FertiQol items were designed to translate abstract concepts (e.g. commitment, sense of belonging) into quantitative items that could collectively indicate the impact of fertility problems on QoL. Full details of item generation for the prototype are described in the Supplemental file and briefly presented here. As shown in Table [I](#DER171TB1){ref-type="table"}, item-generation involved four stages: generating potential items; eliminating redundant, irrelevant and outlier items; validation among people with fertility problems, and cross-cultural survey of acceptability and feasibility. A comprehensive literature review and consultation with psychosocial infertility experts generated an initial pool of 302 items on consequences of fertility problems on QoL in the following 14 areas (e.g. marriage/partnership, social network, emotions, cognitions, coping, treatment, physical health etc.). The authors classified the 302 items into three levels of increasing concept specificity: dimensions (e.g. interpersonal), domains (e.g. partner relationship) and facets (e.g. intimacy) to form groups of items tapping into related aspects of QoL. Classification and subsequent focus groups reduced this pool to 102 items, which were submitted to the acceptability and feasibility study (see Table [I](#DER171TB1){ref-type="table"}). The prototype evaluated in the present study included these 102 Core items and 27 optional treatment items identified through the feasibility and acceptability phase. Table IFertiQoL item generation, selection and reduction.Task and aimsParticipantsMaterialsOutcomeLiterature review and expert consultation to generate potential itemsPsychosocial experts in reproductive health (*n* = 17)Psychosocial studies302 items in 14 domains (e.g. partnership, self-esteem and career)FertiQoL Steering Committee (*n* = 10)Existing fertility-related toolsGroups included: researchers, psychologists, social workers, counselors, patients, gynecologists, nurses, clinicians in 11 countries: Australia, Canada, Denmark, France, Germany, Italy, New Zealand, Sweden, Switzerland, UK, USATreatment evaluation toolsQoL measuresWHO development manualClassification and reduction of item pool to eliminate redundant or irrelevant items or rare QoL effectsFertiQoL Technical Working Group (Boivin, Takefman, Braverman) and expert panelWHO selection criteria: items should be revealing of QoL, cover key domains, use simple language, ask about single issues, free of ambiguity, etcItem pool reduced to 116 itemsWHO response scales matched to itemsFocus groups with patients to validate the items generated by the experts and uncover any effects overlooked by the experts17 focus groups (*n* = 136 participants): Canada, Germany, Mexico, USA, Italy^a^Structured interview guide (facilitators), workbooks (participants) and 116 item-pool FertiQoLItem decrease from 116 to 102 (22 items eliminated and 8 added) based on \> or \<50% endorsementPurposive sampling for age (\< or \>35 years), gender, duration of infertility (\< or \>2 years) and parity (\< or \>1 child)Added 18 treatment items; Wording corrected; eliminated and/or combined redundant items; improved face validity; ensured items pertained to QoL and response scale appropriatePsychosocial experts facilitated open, unstructured discussion groups followed by structured feedback exercise on FertiQoL item pool; duration 1.5--2 hSurvey to assess acceptability and feasibility of FertiQoL item style in different languages*n* = 525 men and women in 10 countries: Argentina (*n* = 48), Brazil (*n* = 96), Canada (*n* = 59), France (*n* = 63), Germany (*n* = 37), Greece (*n* = 32), Italy (*n* = 47), Mexico (*n* = 46), New Zealand (*n* = 11), Spain (*n* = 43), UK (*n* = 79) and the USA (*n* = 43)102 Core FertiQoL + 27 optional treatment itemsFinal Core FertiQol pool for psychometric phase was 102 items + 27 optional Treatment itemsAdditional items inquired about clarity, coverage and problems with item poolFertiQoL well accepted, perceived to be important and timelyMaterial translated by expertsItems easy to understand and relevantFertiQoL completing 15--20 minMain problems: items that did not apply to all people (e.g. single or untreated) and timeframe for \'Instructions\' required[^2][^3]

Translation {#s2c}
-----------

FertiQoL was produced in English and translated into 20 languages: Arabic, Chinese, Croatian, Danish, Dutch, English, Finnish, French, German, Greek, Hindi, Italian, Portuguese, Romanian, Russian, Serbian, Spanish, Swedish, Turkish and Vietnamese (see [www.fertiqol.org](www.fertiqol.org) to download FertiQoL; Korean and Hungarian versions in progress). Cardiff University professional translators carried out the first translation, and two local fertility experts reviewed it to ensure that it was appropriate to local customs and fertility word usage. Cross-cultural data will be presented in a separate paper.

Procedure {#s2d}
---------

The items in the prototype FertiQoL survey were randomly presented and rated on a scale of 0--4, where higher scores indicated more favorable QoL. The online survey (prototype FertiQoL and Background Information Form) was designed using SurveyTracker software for Training Technologies, inc and the paper version for clinic distribution was designed using InDesign. Webmasters were provided with a hyperlink to the survey. In clinics, FertiQoL coordinators at each site distributed the study pack to consecutive patients who returned completed surveys anonymously in a marked collection box in the patient waiting room.

Statistical analysis {#s2e}
--------------------

Data were screened and duplicate internet protocol (IP) addresses were eliminated unless of different gender and response pattern. Descriptive statistics and correlations were used to identify the best items for each *a priori* domain of QoL (e.g. emotional, mind/body, relational and social). This *a priori* work was done to ensure that conceptually similar groups of items were entered into the factor analysis. Factor analyses (orthogonal rotation) were computed (clinic, online) to ascertain relations among these items. Items with factor loadings less than 0.30 and eigenvalues less than one were eliminated. The FertiQoL total and subscale scores were computed and transformed to scaled scores and summary statistics (e.g. reliability coefficient, mean and standard deviation) produced. Scaled scores were computed to achieve a range of 0--100, making comparisons between scales easier. For scaling, items were reverse-scored (where necessary); all items then summed and multiplied by 25/k, where *k* was the number of items in the desired subscale or total scale. Higher scores mean better QoL. For the sake of brevity, only final analyses are shown here. These analyses generated the final FertiQoL, which composed 24 core items, plus 10 optional treatment items). See [www.fertiqol.org](www.fertiqol.org) for final FertiQoL in all languages and for scoring instructions.

Results {#s3}
=======

Sample characteristics {#s3a}
----------------------

Table [II](#DER171TB2){ref-type="table"} shows background characteristics and these show that the Clinic group were older, and included more men, single women, same-sex couples and people with a university-education, but fewer American and UK residents and people living in rural/suburban areas compared with the Online sample. The Clinic sample was more likely to have at least one child, a shorter duration of infertility but less likely to have other health problems. Table IIDemographic characteristics of the online and clinic samples^a^.VariableOnline (*n* = 1048)Clinic (*n* = 366)Test statistic (*χ*^2^ or *t*)Demographic Age in years mean (SD)32.9 (4.9)35.2 (4.0)7.9^b^ Women % (*n*)96.8 (1014)79.5 (291)113.4^b^ Relationship status % (*n*)49.4^b^ Single0.2 (3)4.0 (13)In stable relationship Same-sex1.7 (18)6.2 (20) Heterosexual98.0 (1027)89.8 (289)Years in partnership mean (SD)^d^6.85 (3.9)7.0 (3.9)0.6University education (% yes, *n*)57.1 (598)66.2 (139)9.5^c^Residence % (*n*)40.4^b^ Urban28.3 (296)27.1 (95) Suburban55.8 (584)69.5 (244) Rural15.9 (166)3.4 (12)Country % (*n*)243.4^b^ Australia/NZ14.5 (152)25.1 (92) Canada10.3 (108)42.0 (154) UK8.7 (91)2.7 (10) USA64.1 (672)30.2 (111) Other2.4 (25)---Reproductive characteristics Parenthood % (*n*)18.9 (197)30.1 (108)19.8^b^ Years infertile mean (SD)3.4 (2.9)2.9 (2.0)2.4^c^ Know why infertile, % (*n*)75.4 (79070.3 (225)3.3 Perceived diagnosis % (*n*)82.4^b^  Unexplained10.9 (86)14.0 (38)  Female factor44.5 (351)18.0 (49)  Male factor19.9 (157)21.7 (59)  Mixed11.9 (94)14.7 (40)  Same-sex1.6 (13)3.3 (9)  Age-related4.1 (32)8.8 (24)  Other7.1 (56)19.5 (53)Other health problems % (n)30.8 (309)24.0 (260)5.8^c^Years treated mean (SD)2.03 (2.4)2.43 (1.8)1.6[^4][^5][^6][^7][^8]

Item analyses {#s3b}
-------------

Descriptive and inferential statistics were used to screen for problematic items. Items were deleted for several reasons \[i.e. highly skewed distribution, high inter-correlations (of \>0.80 among item set), poor scale coherence, interpretive issues\]. Other items were deleted because they measured broad constructs (e.g. self-esteem) that could be better captured by measures designed for that purpose and that, if retained, would confound associations with those measures in future research. The final FertiQoL item set submitted for exploratory factor analysis was comprised of 24 items from the core set of items and 10 items from the optional treatment module. The 24 core items were conceptualized as reflecting QoL in the emotional, mind-body (i.e. cognitive and physical), relational and social domains. The 10 optional treatment items were conceptualized as indexing treatment environment and treatment tolerability. An additional two items measuring satisfaction with QoL and physical health were retained for the FertiQoL measure to indicate general physical and QoL satisfaction, but were not included in the factor analysis.

Exploratory factor analyses and internal consistency {#s3c}
----------------------------------------------------

Kaiser-Meyer-Olkin measures of sampling adequacy were \>0.80 demonstrating sufficient inter-correlation among items to perform factor analyses. Table [III](#DER171TB3){ref-type="table"} shows factor loadings for the Online and (in parenthesis) Clinic samples for the Core FertiQoL and Optional Treatment Module domains. The first factor explaining item variance in the Core FertiQoL was the Emotional subscale explaining 31.8% (Online) and 37.8% (Clinic) of the item variability. Other factors (mind/body, relational and social) explained 10% or less of the item variance but all eigenvalues were above one. Loadings showed that items conceptualized to tap into the same concepts all had high factor loadings (\>0.30) on their designated factor. Cross-loadings were observed for items of the mind/body (i.e. concentration, life on hold) and social domains (i.e. isolation, shame) onto the emotional domains. For the Optional Treatment Module, the first factor was Treatment Environment, explaining 34.0% (Online) and 38.0% (Clinic) of item variance. There were no cross-loadings for the Treatment Quality and Treatment Tolerability subscales. Table [IV](#DER171TB4){ref-type="table"} shows summary information for all FertiQoL scales. Core FertiQoL and Treatment FertiQoL were normally distributed and individual subscales were normally distributed (data not shown), with only the relational subscale showing mild positive skew toward more favorable QoL in this domain. Table IIIFactor loadings for online and clinic (in parenthesis) samples on FertiQoL items.Core FertiQoLOptional Treatment FertiQoL moduleEmotionalRelationalMind/bodySocialTreatment environmentTreatment tolerability**Angry**0.752 (0.800)Grief/loss0.763 (0.792)Sad/depressed0.730 (0.772)Fluctuate hope/despair0.643 (0.759)Jealousy and resentment0.737 (0.634)Unable to cope0.640 (0.594)**Affectionate**0.749 (0.732)Difficult to talk0.629 (0.696)Negative impact on relationship0.707 (0.633)Content relationship0.768 (0.616)Strengthen relationship0.713 (0.603)Satisfied sexual relationship0.575 (0.600)**Fatigue**0.731 (0.745)Pain/discomfort0.566 (0.663)Feel worn out^b^0.620 (0.627)Disrupt activities0.704 (0.625)Concentration(0.634)^a^0.554 (0.413)Life on hold^b^(0.577)^a^0.572 (0.355)**Family understand**0.669 (0.669)Friend support0.751 (0.649)Society expect0.495 (0.446)Isolated(0.558)^a^0.509 (0.531)Handle/pregnant others^b^0.538^a^ (0.589)^a^0.306 (0.350)Shame, embarrassment^b^0.527^a^ (0.580)^a^0.319 (0.440)**Interactions with staff**0.813 (0.784)Quality treatment information0.802 (0.784)Quality surgery and medical treatment0.780 (0.763)Fertility staff understand us0.728 (0.750)**Quality emotional services**0.632 (0.664)Medical services desired available0.576 (0.585)Bothered effect daily activities and work0.799 (0.790)Bothered physical effects0.792 (0.732)Complicated medication and procedures0.645 (0.715)Treatment effects on mood0.645 (0.681)Online eigenvalue (% variance)7.62 (31.8)2.61 (10.9)1.44 (6.0)1.16 (4.8)3.48 (34.9)1.92 (19.3)Clinic eigenvalue (% variance)8.93 (37.8)2.37 (9.9)1.23 (5.1)1.08 (4.5)3.80 (38.0)1.68 (16.8)[^9][^10][^11][^12] Table IVMeans and standard deviations for FertiQoL subscales and total scaled scores for the validation sample (online, clinic combined).Scale*n*QoL domainNumber of itemsCronbach alphaMean (SD) Scaled score 0--100Core subscales Emotional1349Impact on emotions (e.g. causes sadness, resentment, grief)60.9045.10 (23.2) Mind-body1338Impact on physical health (e.g. fatigue, pain), cognition (e.g. poor concentration) and behavior (e.g. disrupted daily activities)60.8454.86 (21.2) Relational1330Impact on partnership (e.g. sexuality, communication and commitment)60.8068.70 (19.2) Social1343Impact on social aspects (e.g. social inclusion, expectations and support)60.7551.10 (20.6)***Core FertiQoL*1226Average quality of life in all core domains240.9254.60 (16.8)Treatment subscales** Environment1072Impacts related to treatment environment (e.g. access, quality, interactions with staff)60.8461.53 (19.6) Treatment tolerability1093Impacts due to consequences of treatment (e.g. physical and mode effects, daily disruptions)40.7258.81 (20.6)***Treatment FertiQoL*1043Average quality of life for all treatment domains100.8160.43 (16.2)*Total FertiQoL*930Average quality of life for all core and treatment domains340.9255.43 (14.8)**[^13]

Sensitivity analyses for sub-scales and total scores {#s3d}
----------------------------------------------------

Potential moderators of QoL (gender, parenthood status and recruitment source) were examined in relation to FertiQoL scores. Women had a significantly lower Core FertiQoL (*M* = 53.3, SD = 16.2) than did men (*M* = 72.1, SD = 14.7) (*t*(1224) = 10.3, *P* \< 0.001). Core FertiQoL was significantly lower for participants without children (*M* = 53.3, SD = 16.3) than participants with children (*M* = 59.5, SD = 17.7) (*t*(1217) = 5.27, *P* \< 0.001). Participants recruited from the online patient advocacy and support sites had significantly lower scores (*M* = 50.7, SD = 15.1) than did participants recruited from clinics (*M* = 67.8, SD = 15.6) (*t*(1224) = 16.6, *P* \< 0.001).

The relationship between treatment subscales and six treatment persistence items (e.g. likelihood of trying further treatment, couple agreeing to persist, thinking of ending treatment) was also examined. Greater intention to persist with treatment was significantly associated with better Treatment FertiQoL (*r*(1026) = 0.172, *P* \< 0.001), especially in the Clinic sample (*r*(206) = 0.289, *P* \<0.001).

Discussion {#s4}
==========

It is currently accepted that to effectively measure the impact of disease, one needs a disease-specific instrument ([@DER171C21]). FertiQol is a reliable and sensitive measurement tool for QoL in individuals with fertility problems. More than 2000 people with fertility problems contributed to the creation of FertiQoL, and it was developed using an integrated mixed-method approach that included literature reviews, international expert consultations, patient focus groups, a cross-cultural feasibility and acceptability survey, and a psychometric survey evaluation. FertiQoL comprises of a Core module evaluating the impact of fertility problems on emotional, mind-body, relational and social domains and an optional Treatment module evaluating treatment environment and tolerability. Subscales and total scales show mainly high reliability and sensitivity of FertiQoL to well-established moderators of QoL. FertiQoL is available in 20 languages with more translations in progress. This project was fully realized as a result of collaboration among ESHRE, ASRM and Merck S.A. Geneva-Switzerland (an affiliate of Merck KGaA Darmstadt, Germany). It is expected that FertiQoL will significantly contribute to future research and clinical endeavors aimed at investigating and ultimately improving QoL in people with fertility problems.

Certain methodological limitations need to be taken into account. First, despite the multi-disciplinary contributions from experts worldwide, focus groups and a feasibility and acceptability study in 10 countries, the final psychometric evaluation only occurred in five English-speaking countries. Second, targeted efforts to recruit a diverse group of people were not entirely successful in recruiting particular subgroups (i.e. secondary infertile, men). Indeed, more psychometric research on men is required to fully establish reliability and validity. Third, the major proportion of the final sample was recruited online, and differences between the Online and Clinic sample were observed. Although, data generated online have been shown to be as valid as data collected through traditional methods ([@DER171C4]; [@DER171C10]), one would need to determine whether the differences observed warrant a more in-depth analysis---for example, a different set of norms for clinic samples. We eliminated records coming from the same IP address but it may be possible that the same person replied more than once to the survey. Finally, the subscales of the Core FertiQoL were not entirely orthogonal with cross-loadings on the social and mind/body domains. While these associations are expected, we have now modified the final wording of four FertiQoL items to reduce these cross-loadings. Further evaluation of these changes and FertiQoL as a whole on a new sample is required for final validation. These main limitations should be addressed in future psychometric research evaluating FertiQoL. However, the strengths of our mixed-method approach, and consultation and evaluation from infertile people ensure that FertiQoL captures the key life domains affected by fertility problems. It is hoped that FertiQoL will become a gold standard for the measurement of QoL for individuals experiencing fertility problems (whether in treatment or not).

FertiQol will be useful to clinicians and researchers alike. FertiQoL can be used to identify people at risk of impaired QoL so that psychosocial resources can be offered and subscale scores could identify the specific domains where intervention might be most beneficial. Recent research has shown a close correspondence between Core FertiQoL and standardized measures of anxiety and depression in a Dutch sample ([@DER171C22]). The availability of FertiQoL in 20 languages will facilitate essential cross-cultural research, particularly in developing nations ([@DER171C13]; [@DER171C17]). However, whether cross-cultural differences exist, whether different populations have different mean scores and whether separate cultural norms are needed are all important questions that need to be addressed in future research.

A unique aspect of FertiQoL compared with other QoL measures is the optional 10-item treatment module. This module measures QoL in respect of treatment quality (interactions with staff, quality of information), and treatment tolerability (effects on mood, disruptions daily life). These subscales can be used to assess effectiveness of new treatments/medications, to monitor quality of services and to optimize patient treatment experiences. Research has shown that quality of treatment and its tolerability are predictors of treatment satisfaction ([@DER171C6]) and willingness to persist with treatment ([@DER171C12]), the latter also shown in the present study. Further a recent large, multi-centered study showed a strong association between a high level of patient-centered care and favorable FertiQoL scores ([@DER171C1]). However, the sensitivity of Treatment FertiQoL for these purposes needs to be investigated in clinical trials of new interventions.

In conclusion, the overall aim of the FertiQoL project was to develop an international instrument to measure QoL in men and women experiencing fertility problems, with the collaboration of individuals experiencing fertility problems and international experts in the field. This objective was accomplished and future use of FertiQoL will be essential to establish FertiQoL as an essential measurement tool for practice, research, health service-evaluation and policy-making.
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[^2]: WHO, World Health Organization; TWG, technical working group (Boivin, Takefman, Braverman). FertiQoL TWG involved in all aspects of project development.

[^3]: ^a^Focus groups in Singapore cancelled due to the Severe Acute Respiratory Syndrome (SARS) virus.

[^4]: A total of 491 people did not provide data years of treatment due to no treatment experience or missing data.

[^5]: ^a^Sample size varies per variable.

[^6]: ^b^*P* \< 0.001.

[^7]: ^c^*P* \< 0.05.

[^8]: ^d^For people in partnerships.

[^9]: Bold indicates first item of each domain.

[^10]: Some items reversed to avoid negative loadings. See [www.fertiqol.org](www.fertiqol.org) for final FertiQoL item wording, response scale wording and downloads in 20 languages. Only factor loadings \>0.30 are shown. Factor loadings for Clinic sample in parenthesis.

[^11]: ^a^Indicates a cross-loadings.

[^12]: ^b^Wording for these items changed as a result of psychometric evaluation and participant feedback.

[^13]: All items reversed or scored so that higher scores indicate more favorable QoL. Core FertiQoL refers to see [www.fertiqol.org](www.fertiqol.org) for final FertiQoL items, response scale wording and downloads in 20 languages. Bold refers to total scores.
